verapamil has been researched along with hymecromone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Hou, JW; Kang, P; Lan, JS; Liu, Y; Xie, SS; Zhang, T; Zhang, XY | 1 |
| Grube, M; Kroemer, HK; Kunert-Keil, C; Sperker, B | 1 |
2 other study(ies) available for verapamil and hymecromone
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Protein Aggregates; Pyridinium Compounds; Rats; Structure-Activity Relationship | 2017 |
Verapamil regulates activity and mRNA-expression of human beta-glucuronidase in HepG2 cells.
Topics: Blotting, Western; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Genes, Reporter; Glucuronidase; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hymecromone; Liver Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Stereoisomerism; Time Factors; Transfection; Verapamil | 2003 |